Related by context. All words. (Click for frequent words.) 63 regenerative medicine 63 tissue regeneration 62 stem cell therapeutics 62 molecular biomarkers 62 regenerative medicine therapies 61 GGF2 60 cartilage regeneration 60 therapeutic monoclonal antibodies 60 stem cell therapies 60 therapies 59 monoclonal antibody therapeutics 59 therapeutics 59 autologous adult 59 cellular immunotherapy 59 therapeutic modalities 59 Pervasis 59 therapeutic monoclonal antibody 58 autologous cell 58 induced pluripotent stem cell 58 cell transplantation 58 DiaKine 58 cellular reprogramming 58 Velcura 58 Chrysalin 58 novel peptide 58 iPSC technology 58 siRNA therapeutics 58 adult mesenchymal stem 58 theranostic 58 novel peptides 57 stem cell therapy 57 regenerative therapy 57 VSELs 57 autologous bone marrow 57 stem cell differentiation 57 immunotherapeutics 57 atherosclerosis regression 57 stem cells 57 Myoblast Program 57 Fibrocell Science 57 Factor VIIa 57 genomic discoveries 57 MYO VAD TM 57 Nanotope 56 Novocell 56 neural stem cell 56 peptide therapeutics 56 interventional therapies 56 Plureon 56 prostone 56 parthenogenetic stem cells 56 Neogenix 56 adipose derived stem cell 56 mesenchymal stem cells MSCs 56 iPSC 56 synthetic biomaterials 56 therapeutic proteins 56 biomaterials 56 ESBA# 56 transplanting stem cells 56 antibody fragment therapeutics 56 diagnostic assays 56 small molecule inhibitors 56 OrthoCyte 56 Cx# [002] 56 novel therapeutics 56 Charlesson 56 biomarker assays 56 pharmacological chaperone 56 Curaxin 56 Myocet 56 Nanobody ® 56 antiviral therapeutics 56 molecular profiling 56 Celator 56 Stemgent 55 Rutherford Procedure 55 small molecule activators 55 LNP formulations 55 nanomedicines 55 adult stem cells 55 SGLT inhibitors 55 NovaBay Aganocide compounds 55 Trophos 55 novel RNAi therapeutics 55 hedgehog pathway 55 Epitomics 55 biotherapeutics 55 NTDDS 55 Ensysce 55 juvenile chondrocytes 55 sd rxRNA compounds 55 biologic therapeutics 55 hESC derived 55 rxRNA 55 nonembryonic 55 biotherapeutic 55 transdifferentiation 55 oncology therapeutics 55 therapeutic 55 bioactive peptides 55 Myotech 55 biomaterial 55 pluripotent stem cell 55 P#X# 55 KineMed 55 antibody therapeutics 55 placental stem cells 55 novel immunotherapies 55 immatics 55 immunoregulation 55 AAV vector 55 zinc finger nucleases 55 bone marrow stem cells 55 Selective Electrochemical Tumor Ablation 54 sd rxRNA 54 LEX System 54 ReCyte 54 multipotent stem cells 54 Scancell 54 predictive toxicology 54 validating biomarkers 54 Celution TM System 54 TKM ApoB 54 antisense oligonucleotides 54 neurotrophic factors 54 Tβ4 54 degenerative disorders 54 Regenerative medicine 54 anticoagulant reversing agent 54 unspecialized cells 54 Litx 54 immune modulation 54 ReN# 54 biotherapies 54 Neuradiab 54 translational research 54 AutoloGel tm System 54 ACTCellerate 54 axon regeneration 54 MAXY VII 54 kallikrein 54 investigational therapies 54 anticancer therapeutics 54 endogenous stem cells 54 Axial Biotech 54 Humacyte 54 aTyr Pharma 54 anti infective treatments 54 regenerative stem cell 54 anticancer therapies 54 antisense drugs 54 Induced pluripotent stem cells 54 keratinocyte 54 polyclonal antibodies 54 regenerate tissue 54 siRNA therapeutic 54 human neural stem 54 Nasdaq ASTM 54 genomic sequencing 54 insulin secreting cells 54 therapeutic peptides 54 genomic profiling 54 PsychoGenics 54 Phage Pharmaceuticals 54 CellerateRx R 54 bioartificial liver 54 immunological diseases 54 immunotherapeutic approaches 54 EECP ® therapy 54 adipose derived stem cells 54 selective kinase inhibitors 54 Altrazeal TM 54 Cethrin 54 kidney urologic 54 novel antiviral therapeutics 54 bioengineered tissue 54 MYOTECH 54 Mesenchymal stem cells 54 therapeutic interventions 54 bioresorbable 53 ZFP technology 53 HepDirect technology 53 Combivir Kivexa 53 Mesoblast Limited ASX MSB 53 AAGP ™ 53 AMPK activators 53 therapeutic modality 53 ISTO 53 NexACT 53 isoform selective 53 recombinant antibodies 53 neural cells 53 antibody therapies 53 intestinal stem cells 53 Oramed 53 Arteriocyte 53 adipose stem cells 53 Neo Kidney Augment 53 miRNA therapeutics 53 haematopoietic stem cells 53 AxoGen 53 Pancreate ™ 53 OTCBB HXBM developer 53 therapeutics diagnostics 53 therapeutically useful 53 otelixizumab 53 biologic therapies 53 PhotoThera 53 immunotherapies 53 ReN# therapy 53 musculoskeletal tissues 53 epigenetic therapeutics 53 telomerase activator 53 CDK inhibitors 53 human hepatocytes 53 rBChE 53 NEUMUNE 53 Biopump 53 Edward Lanphier Sangamo 53 TKM PLK1 53 DiaKine Therapeutics 53 regenerating bone 53 myoblast cells 53 NASDAQ OPXA 53 CVBT #B 53 BHT DNA 53 adipose stem 53 bone marrow derived 53 bone marrow derived mesenchymal 53 LensAR 53 Inc. Nasdaq NLTX 53 predictive biomarkers 53 Prodarsan R 53 NIC5 53 molecular radiotherapeutics 53 adult stem cell 53 genomic proteomic 53 Adipose derived 53 Stapled Peptide 53 GPR# agonists 53 thymosin beta 4 53 tissue fibrosis 53 TB4 53 RNAi therapeutic targeting 53 sirtuin therapeutics 53 PLX cells 53 Celling Technologies 53 Cerashield 53 StromaCel 53 OMP #R# 53 Myolimus 53 HDL Mimetic Peptide 53 commercialize microRNA 53 TÎ ² 4 53 PROfusion 53 ALN PCS 53 refractory angina 53 therapeutic antibody 53 Receptos 53 AutoloGel tm 53 teplizumab 53 Adnectin 53 Phase IIb clinical trials 53 humanized antibodies 53 retinal disorders 53 Cellerant 53 biopharmaceuticals 53 IAP inhibitors 53 ZFP Therapeutics 53 MYO VAD 53 Sangamo ZFP technology 53 Tectin TM 53 immuno inflammatory diseases 53 mesenchymal stem cells 53 Vascular Endothelial Growth 53 pluripotent stem cells 53 tissue scaffolds 53 LifeStem 53 Symadex 53 pharmacologic approaches 53 Embryome Sciences 52 innovative microdroplet based 52 human parthenogenetic stem 52 Quark Biotech Inc. 52 iPierian 52 novel therapeutic antibodies 52 proliferative diseases 52 Galenea 52 Intarcia 52 GPCR targets 52 eTag assays 52 OncoVEX 52 optimal dosing regimens 52 autologous cells 52 Ataluren 52 Cytochroma 52 antibody reagents 52 anti CD# antibodies 52 antisense inhibitors 52 BARRX Medical Inc. 52 ZFP TF 52 GRNCM1 52 PDE# inhibitors 52 anticancer compounds 52 pro angiogenic 52 biologic 52 MEK inhibitors 52 vitamin D analogs 52 OTCBB NRGX biotechnology 52 systemic RNAi 52 adipose derived regenerative 52 neuromodulation therapies 52 OTCBB ACTC 52 therapeutic antibodies 52 RNA interference RNAi therapeutics 52 OGeS 52 carbohydrate compounds 52 skeletal muscle contractility 52 InVivo Therapeutics OTCBB 52 neuro degenerative diseases 52 neural regeneration 52 ZFP Therapeutic 52 Cerenis 52 Gamida Cell 52 MAPCs 52 minimally invasive treatments 52 bioprinting 52 bone marrow stem cell 52 neurotechnology 52 Relypsa 52 A3 adenosine receptor 52 Scil Proteins 52 RayBiotech 52 ophthalmic therapeutics 52 Preclinical studies suggest 52 MultiCell Technologies 52 vaccine GRNVAC1 52 hES cells 52 MolecularBreeding 52 Amarantus 52 GAP #B# 52 ALN TTR# 52 nicotinic alpha 7 52 adipose tissue derived 52 protein homeostasis 52 Homspera 52 autologous cellular therapies 52 bioinnovation 52 Novosom 52 orthobiologic 52 Gentel Biosciences 52 JAK3 52 THR beta agonist 52 resolvins 52 Promedior 52 dermaPACE TM 52 mesenchymal stem cell 52 microRNA biology 52 amniotic stem cells 52 anti angiogenic drugs 52 DOS# 52 retinal pigment epithelium 52 cancer immunotherapies 52 JAK inhibitors 52 Sopherion 52 novel antibody therapeutics 52 targeting PCSK9 52 adipose derived stem 52 pharmacologic intervention 52 OxBC 52 NYSE Amex PBTH 52 DsiRNA 52 validate biomarkers 52 MultiStem 52 Dr. Rafii 52 Etubics 52 progenitor cell 52 HepDirect 52 TRV# [001] 52 diagnostic molecular imaging 52 talactoferrin 52 photodisinfection 52 Wnt signaling pathway 52 iPS cell 52 induced pluripotent stem iPS 52 genetic biomarkers 52 synthetic genomics 52 PhaseBio 52 OTCBB PYTO FWB ET6 52 OncoMed 52 neurology immunology 52 immunoregulatory 52 vivo validation 52 lentiviral vectors 52 neural stem cells 52 pharmacogenetic test 52 ZFNs 52 VeraTag assays 52 NPC 1C 52 DiFUSION 52 osteoinductive 52 diagnostic prognostic 52 pharmacogenetic testing 52 incyclinide 52 ImmuneY2 52 antibody humanization 52 HQK 52 extracellular matrices 52 autologous cellular therapy 52 epigenomics 52 immune modulatory 52 JAK1 52 TSX VENTURE SVA 52 FTIs 52 Fibroblast Growth Factor Receptor 52 BioCart ™ System 52 poly ethylene glycol PEG 52 microRNA therapeutics 52 tiapamil 52 biosurgical 52 Ilypsa 52 bionanotechnology 52 Excellagen TM 52 MDSCs 52 Gemin X 52 Facet Solutions 52 TetraLogic 52 Hemospan 52 embolotherapy 52 romazarit 52 deacetylase inhibitors 52 SpineSmith 52 topical formulations 52 HemoTech TM 52 MyVax ® 52 biomarker discovery 52 vascular disrupting agents 52 ocular diseases 52 Versartis 51 proprietary encapsulation 51 anti fibrotic 51 DXL# 51 recombinant factor VIIa 51 thrombotic diseases 51 HuCNS SC ® 51 DispersinB R 51 Squalamine 51 StromaCel Inc. 51 recombinant protein therapeutics 51 progenitor cells 51 noninvasive prenatal tests 51 Brussels THR 51 CBLC# 51 stated Gord Froehlich 51 neurotrophic 51 SomatoKine 51 protein therapeutics 51 NanoString 51 placental derived 51 Campath alemtuzumab 51 HyperBranch 51 HepaLife 51 DermTech 51 Fibrin MB 51 HepDirect R 51 bone marrow aspirates 51 resorbable biomaterials 51 PrimeGen Biotech 51 BrachySil TM 51 AMPAKINE 51 Smac mimetics 51 Chemokine Therapeutics 51 MultiStem ® 51 Neural stem cells 51 vaccines oncolytic virus 51 neuropilin 51 immunologic diseases 51 bio therapeutics 51 Affibody ® molecules 51 Selexis 51 ACTCellerate TM 51 rxRNA TM compounds 51 targeted antifolate 51 preclinical 51 shRNA libraries 51 stem cell biology 51 Hybridon 51 Anticalins R 51 stem cell 51 Aastrom 51 theranostics 51 humanized monoclonal antibodies 51 Nektar proprietary 51 allogeneic cell 51 CB1 antagonists 51 JAK2 inhibitors 51 PermaDerm TM 51 small molecule 51 proprietary biomaterials 51 Tissue Repair 51 MyoCell TM 51 adrenergic regulation 51 sodium glucose transporter 51 PharmaFrontiers 51 Nanobodies ® 51 bioartificial liver device 51 acetonide FA 51 Locked Nucleic Acid LNA 51 Ambrx 51 PRNewswire FirstCall Derma Sciences 51 proteomic analysis 51 targeted pulsed electromagnetic 51 Corgentin 51 novel radiopharmaceuticals 51 intranasal delivery 51 Opsona 51 Raymedica 51 drug GAP #B# 51 Oncobionic 51 Cethrin R 51 HDL Selective Delipidation 51 degenerative diseases 51 Carticept 51 small molecule modulators 51 selective androgen receptor modulators 51 Functional Somatic Syndromes 51 vivo molecular imaging 51 GED aPC 51 targeted radiotherapeutic 51 Anaphore 51 ViaCyte 51 skeletal muscle weakness 51 translational medicine 51 Nautilus Biotech 51 candidate deforolimus 51 CCR9 antagonist 51 HCV antiviral 51 Pyridorin 51 investigational monoclonal antibody 51 AutoloGel System 51 Nuron Biotech 51 Panzem 51 cardiovascular stents 51 molecular chaperone regulation 51 mimetics 51 ISTO Technologies Inc. 51 blood plasma expander 51 AFIRM 51 viral inactivation 51 Altrazeal ® 51 oligonucleotide therapeutics 51 oligodendrocyte progenitor cells 51 regenerative tissue 51 NP2 Enkephalin 51 myogenesis 51 Vascugel R 51 Neo Bladder Augment 51 CureDM 51 ActivX 51 periodontal tissue 51 diagnostic biomarkers 51 ACTCellerate ™ 51 TNF alpha antagonist 51 mda 7 51 Mipomersen 51 EnzymeRx 51 LentiVector 51 BoneScalpel 51 Proneuron 51 purinergic receptors P#X# 51 Guanilib 51 undifferentiated stem cells 51 Optivia Biotechnology 51 Cyntellect 51 endometrial regenerative cells 51 oncolytic viruses 51 transcutaneous immunization TCI 51 small molecule therapeutics 51 peptide mimetics 51 Stem Cell Assurance 51 LentiVector technology 51 immunotoxins 51 Exelixis compounds 51 MOZOBIL 51 Resolvyx Pharmaceuticals 51 ddRNAi 51 Nasdaq HALO biopharmaceutical 51 ProMune 51 Enkephalin 51 Inc. OTCBB PLRS 51 Personalized medicine 51 carbon nanomaterials 51 Pervasis Therapeutics Inc. 51 bioartificial 51 recombinant therapies 51 extracellular matrix ECM 51 protein kinase inhibitors 51 EP #R 51 PolyTouch 51 neuroprotective therapies 51 Behcet uveitis 51 gene therapy 51 rxRNA compounds 51 FoldRx 51 treatments 51 CFTR inhibitors 51 biotherapy 51 IR BioSciences Holdings 51 molecular imaging radiopharmaceutical 51 enGene 51 Ikonisys 51 Peptidomics 51 EyeGate 51 stent coating 51 therapeutic radiopharmaceuticals 51 inhibit metastasis 51 TransMolecular 51 Dr. Grekos 51 bioactive molecules 51 telomerase activation 51 LifeGen Technologies 51 RECOTHROM ® 51 hES cell 51 renin inhibitors 51 Medistem 51 commercializes therapeutics 51 neurodegenerative diseases 51 Locked Nucleic Acid 51 Lycera 51 TLR Therapeutics 51 Epeius Biotechnologies Corporation 51 vascular disorders 51 biochemical profiling 51 HCV protease inhibitors 51 BioSeek 51 wound healing 51 pancreatic tissue 51 Sernova 51 axonal regeneration 51 Metallophile ™ Technology 51 fusion proteins 51 protein misfolding 51 repopulate neural 51 Helix BioMedix 51 RNAi therapeutic targeting PCSK9 51 Cytori NASDAQ CYTX 51 mesenchymal cells 51 therapeutic apheresis 50 Tissue Genesis 50 Regado 50 Codon Devices 50 RNAi therapeutic 50 NovaThera 50 E1 INT TM 50 Molecular Biometrics 50 MEK inhibitor 50 PINK MBLTY 50 GRN# 50 Optimata 50 MDRNA proprietary 50 AVANCE Nerve Graft 50 cell hESC 50 Hepregen 50 molecular chaperone amplification 50 islet transplantation 50 PluriCells TM 50 Mesd 50 Stemedica 50 investigational compounds 50 ORTHOCON 50 lipid nanoparticle LNP 50 deriving stem cells 50 Phylomer ® 50 uricase 50 Aquinox 50 nanomedicine 50 ProChon Biotech Ltd. 50 IgG1 antibodies 50 ocular disorders 50 biomarker 50 PERCIVIA 50 Factor NGF 50 Adenosine Therapeutics 50 Semafore 50 SGLT Inhibitors 50 MacroPore 50 Bendavia 50 VitiGam 50 Follica 50 Inc. Nasdaq INFI 50 Myotech CSS 50 PHER O2 50 Aegera 50 Excelimmune 50 deforolimus 50 neuronal stem cells 50 pancreatic islet cells 50 CNS disorders 50 nanomedical 50 PEGylation technology 50 BioSET 50 OvaRex R 50 Neo Urinary Conduit 50 engineered RAP peptides 50 small molecule thrombopoietin 50 ADME properties 50 UltiMAb 50 superior bioprocessing 50 infantile NCL 50 microRNA biomarkers 50 iPS 50 Banyan Biomarkers 50 CB2 receptor 50 progenitor stem cells 50 HuCNS SC cells 50 Omthera 50 OncoGel 50 SmartChip System 50 Protagen 50 novel anti infective 50 bioprocesses 50 retroviral vectors 50 aptamer therapeutics 50 clinically differentiated 50 immunology oncology 50 myoblast 50 Cobalamin 50 cells hESCs 50 injectable collagenase 50 prenatal diagnostics 50 small molecule PEGylation 50 Platelet Rich Plasma PRP 50 SEPET TM 50 Aurora kinase inhibitors 50 Sertoli cells 50 Bioral 50 biomarker identification 50 Homspera TM 50 CR# vcMMAE 50 Bone Morphogenetic Protein 50 Quanterix 50 lipid metabolites 50 RNAi therapeutics 50 Ibis Biosciences 50 TLR9 agonists 50 Pancreate 50 stem cells derived 50 tranilast 50 Stemcells 50 TNFa 50 siRNA delivery 50 Zyngenia 50 molecular imaging radiopharmaceuticals 50 FluoroPharma 50 Radilex 50 PLK1 SNALP 50 ProFibrix 50 Stratatech 50 Rosetta Genomics Nasdaq ROSG 50 contractile muscle 50 bafetinib 50 #beta HSD1 50 Spiegelmers ® 50 embryonic progenitor cells 50 vivo fluorescence imaging 50 HuCAL antibodies 50 beta islets 50 NurOwn 50 Micro RNAs 50 neuro vascular 50 Symphogen 50 CardioFit 50 HuCAL antibody 50 Amunix 50 QuadraSphere 50 SNALP 50 metabolite profiling 50 Personalized Immunotherapy 50 renin inhibition 50 therapeutic angiogenesis 50 recombinant enzyme 50 ALDH br cells 50 dexanabinol 50 PXD# 50 resorptive 50 MP4 molecule 50 Prodarsan ® 50 oligodendrocyte cells 50 BACcel 50 Dr. Ruoslahti 50 depsipeptide 50 ganaxolone 50 OHR/AVR# 50 Curaxins 50 ophthalmic indications 50 molecular diagnostic assays 50 Revimmune TM 50 RECEPTORS LLC 50 LungExpress Dx TM 50 AAGP TM 50 Lentigen 50 novel immunotherapeutic 50 Bryostatin 50 PEGylated 50 radionuclide therapy 50 OsteoSponge ® SC 50 rxRNA ™ compounds 50 GeneICE 50 therapeutic peptide 50 NexACT ® 50 Fc fusion proteins 50 collagenase 50 Marcadia 50 regenerate tissues 50 metabolomic profiling 50 OTCQB ABPI 50 Spiegelmer 50 Avian Transgenic Technology 50 Mirna Therapeutics 50 TLR8 50 short interfering RNA 50 HepaLife Technologies Inc. 50 SGLT2 inhibitors 50 multitargeted 50 retinal pigment epithelial cells 50 ZFNs clinical trials 50 IR Biosciences 50 Inc. OTCBB CYGX 50 cardiometabolic disorders 50 haematological cancers 50 Cytori Celution System 50 nanobodies 50 iPSCs 50 INFUSE ® 50 Bioheart 50 tRNA synthetases 50 MacuSight 50 multipotent 50 peptide synthesis 50 Optivia 50 molecular chaperone 50 MMP inhibitors 50 RNAi compounds 50 nanocarriers 50 fibroblasts 50 Affimed Therapeutics AG 50 Umbilical cord stem cells 50 glucokinase activator 50 NNRs 50 ProLindac TM 50 Virdante 50 NeurAxon Inc. 50 hematopoietic blood 50 Zemiva TM 50 cardiac myosin 50 nerve regeneration 50 proprietary hydrogel 50 fatty acid biosynthesis 50 CINtec R 50 biologics 50 bone grafting procedures 50 polymerase inhibitors 50 carbohydrate polymers 50 proprietary PEGylation 50 biomarkers 50 neuroprotection 50 insulin analogs 50 Tß4 50 Tarmogen 50 Transfection Reagent 50 Addrenex 50 Inotek Pharmaceuticals Corporation 50 RXi sd rxRNA compounds 50 zinc finger nuclease 50 Nanobodies R 50 ZFN technology 50 companion diagnostics 50 BioSurgery 50 ZFP TFs 50 TOCOSOL Camptothecin 50 fibrin sealant 50 Intellikine 50 Therapeutic antibodies 50 Vaccinex 50 subsidiary Cira Biosciences 50 LEUKINE 50 sensory nerve fibers 50 BIOGUARD TM 50 induced pluripotent stem cells 50 chronic tendonitis regeneration 50 AltheaDx 50 Photodynamic therapy PDT 50 CD# CEA 50 monoclonal antibodies 50 iPS cells 50 rheumatoid arthritis multiple sclerosis 50 Aviptadil 50 Histogenics 50 inhibit angiogenesis 50 Thrombin 50 regenerate diseased 50 Cohera 50 MolecularBreeding TM 50 cancer immunotherapy 50 Neuraltus 50 Neurologix 50 neural progenitor cells 50 endoderm 50 selective inhibition 50 ProChon 50 immuno therapeutic 50 protein misfolding diseases 50 Neurome 50 biocatalytic 50 VitroGro 50 immunotherapy 50 spermatogonial stem cells 50 cellular pathways 50 OTCBB NRGX 50 HepDirect prodrug 49 myoblast therapy 49 PolyTherics 49 Maxy G# 49 Syntonix 49 Diasome 49 CAMBRIDGE Mass. Alnylam Pharmaceuticals 49 molecularly targeted therapies 49 telomerase inhibitor 49 parthenogenetic stem cell 49 angiogenesis inhibition 49 OrCel R 49 epothilone 49 biased ligands 49 NTx TM -# 49 Cardioxyl 49 chimeric protein 49 RNA antagonist 49 transfection reagents 49 stem cell transplantation 49 Parkinson disease Alzheimer disease 49 antiviral therapies 49 histone deacetylase HDAC inhibitors 49 Dr. Pestell 49 miRNA biomarkers 49 adenoviral 49 Angiochem 49 Entegrion 49 Accuri C6 49 tissue homeostasis 49 pathogen inactivation 49 genomics proteomics 49 anticancer therapy 49 MitoSciences 49 therapeutic regimens 49 bone morphogenetic proteins 49 MYDICAR 49 curative therapies 49 RECOTHROM R 49 E2F 49 Trofex 49 ColonRing 49 Metabolon 49 ZFN 49 HDL Therapy 49 biomarker assay 49 Quark Pharmaceuticals 49 oncomodulin 49 Cell TRC 49 HeliScope Sequencer 49 telomerase enzyme 49 ZFP transcription factors 49 derived neurotrophic factor 49 vitro diagnostic tests 49 Biopharma OTCBB VODG 49 Metamark 49 Nektar PEGylation technology 49 synthetic biomaterial 49 Auspex Pharmaceuticals 49 urethral bulking agent 49 compound Protectan CBLB# 49 Sirnaomics 49 Agios Pharmaceuticals 49 Nanobody 49 miltefosine 49 Monoclonal antibody 49 commercialize deforolimus 49 immune modulator 49 Degarelix 49 Stemina 49 acadesine 49 topical dermatology 49 molecular chaperones 49 oncology immunology 49 monoclonal antibodies MAbs 49 HTS assay 49 Proxinium TM 49 amniotic stem cell 49 MD FACS FAAP